Brief: Rhythm Pharmaceuticals Q3 Net Income USD -43.641 Million
05/11/2024 21:01
Nov 05 (Reuters) - Rhythm Pharmaceuticals Q3 operating income USD -43.885 million. * Q3 product revenue USD 33.251 million
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand